Диссертация (1140910), страница 16
Текст из файла (страница 16)
– 2000. – N.58. – P.1211-1218.20.Clase CM. Glomerular filtration rate: screening cannot be recommended onthe basis of current knowledge // BMJ. – 2006. – N.333. – P. 1030-1031.21. Collins AJ, Foley RN, Chavers B, Gilbertson D. et al. US Renal DataSystem 2013 Annual Data Report // American Journal of Kidney Diseases.– 2014. – Vol.63, N.1. – P.
23-40.22.Collins AJ, Vassalotti JA, Wang C, et al. Who should be targeted for CKDscreening? Impact of diabetes, hypertention, and cardiovascular disease //Am J Kidney Dis. – 2009. – N.53, Suppl 3. – 71-77.23.Coresh J, Selvin E, Stevens LA et al. Prevalence of Chronic Kidney Diseasein the United States // JAMA. – 2007. – N.298. – P. 2038-2047.24.Coresh J., Astor B.C., Greene T. et al. Prevalence of chronic kidney diseaseand decreased kidney function in the adult US population: Third NationalHealth and Nutrition Examination Survey // Am. J. Kidney Dis.
- 2003. Vol. 41, №1.- P. 1-12.25.Coresh J., Astor B.C., McQuillian G. et. al. Calibration and randomvariation of the serum creatinine assay as critical elements of usingequations to estimate glomerular filtration rate // Am. J. Kidney Dis. - 2002.- Vol.39, № 5. - P.l-11.26.Coresh J., Byrd-Holt D., Astor Brad C. et al. Chronic kidney diseaseawareness, prevalence, and trends among U.S. adults, 1999 to 2000 // J AmSoc Nephrol. – 2005. – N. 16. – P. 180-188.27. Craig JC, Barratt A, Cumming R, Irwig L, Salkeld G.
Feasibility study ofthe early detection and treatment of renal disease by mass screening // InternMed J. – 2002. – N.32. – P. 6-14.9628.Crowe E, Halpin D, Stevens P. Early identification and management ofchronic kidney disease: summary of NICE guidance // BMJ. – 2008. –N.337. – P. 153029.De Jong P., Hillege H., Pinto-Sietsma SJ. Et al. Screening formicroalbuminuria in the general population: a tool to detect subjects at riskfor progressive renal failure in an early phase? // Nephrol Dial Transplant. –2003. – N.18. – P. 10-13.30.De Jong P.E., Verhave J.C, Pinto-Siestma S.J.
et al. Obesity and targetorgan damage: the kidney // Int. J. Obes. Relat. Metab. Disord. – 2002. –Vol. 26, N. 4. – P. 21-24.31. De Jong PE and Brenner BM. From secondary to primary prevention ofprogressive renal disease: the case for screening for albuminuria // KidneyInternational. – 2004. – N.66. – P. 2109-2118.32. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening forchronic kidney disease: where does Europe go? // Clin J Am Soc Nephrol. –2008. – N.3. – P. 616-623.33. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior toserum creatinine as a marker of kidney function: a meta-analysis // Am JKidney Dis.
– 2002. – N.40. – P. 221—226.34.Dyer A., Greenland P., Elliott P. et al. Evaluation of measures of urinaryalbumin excretion in epidemiological studies // Am J Epidemiol. – 2004. –N.160. – P.1122-1131.35.Finkelstein J., Joshi A., Hise M.K. Association of physical activity andrenal function in subjects with and without metabolic syndrome: a review ofthe Third National Health and Nutrition Examination Survey (NHANES III)// Am.
J. Kidney Dis. – 2006. – Vol. 48, N. 3. – P. 372-382.36. Fliser D., Ritz E. Serum cystatin C concentration as a marker of renaldysfunction in the elderly // Am J Kidney Dis. – 2001. – N.37. – P. 79–83.9737. Forman JP, Brenner BM.
«Hypertension» and «microalbuminuria»: Thebell tolls for thee // Kidney Int. – 2006. – N. 69. – P. 22-28.38.Gansevoort RT, Verhave JC, Hillege HL et al. The validity of screeningbased on spot morning urine samples to detect subjects withmicroalbuminuria in the general population // Kidney International. – 2005N.94, Suppl.1. – P. 28-35.39. Garg AX, Clark WF, Haynes RB, House AA. Moderate renal insufficiencyand the risk of cardiovascular mortality: results from the NHANES I //Kidney Int. – 2002.
– N.61. – P. 1486-94.40.Gerstein H., Mann J., Yi Q. et al. Albuminuria and risk of cardiovascularevents, death, and heart failure in diabetic and nondiabetic individuals //JAMA. – 2001. – N.286. – P. 421-426.41.Gilbetr R., Phillips P., Jerums G. Relationship between ambulatory bloodpressure and albuminuria in normal subjects // Am. J. Hypertens.
– 1991. –N.4. – P. 959-962.42.Glassock RJ and Winearls C. Screening for CKD with eGFR: doubts anddangers // Clinical Journal of The American Society of Nephrology:CJASN. – 2008. – N.3. – P. 1563-1568.43. Glynn LG, Reddan D, Newell J et al. Chronic kidney disease and mortalityand morbidity among patients with established cardiovascular disease: aWest of Ireland community-based cohort study // Nephrol Dial Transplant.– 2007. – v.22, N.9.
–P. 2586-2594.44.Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidneydisease and the risks of death, cardiovascular events, and hospitalization //N Engl J Med. – 2004. – N.351. – P. 1296-1305.45.Grubb A, Nyman U, Bjork J, et al. Simple cystatin C-based predictionequations for glomerular filtration rate compared with the modification ofdiet in renal disease prediction equation for adults and the Schwartz and the98Counahan-Barratt prediction equations for children // Clin Chem. – 2005. –N.51. – P. 1420–1431.46.Grunfeld B., Perelstein E., Simsolo R., et al.
Renal functional reserve andmicroalbuminuria in offspring of hypertensive parents // Hypertension. –1990. – N.15. – P. 257-261.47. Halimi J.M., Forhan A., Balkan B. et al. Ig microalbuminuria an integratedrisk marker for cardiovascular disease and insulin resistance in both menand women? // J. Cardiovasc.
Risk. - 2001. - Vol. 8. - P. 139-146.48. Hallan S, Astor BC, Lydersen S. Estimating glomerular filtration rate in thegeneral population: the second Health Survey of Nord Trondelag (HUNT II)// Nephrol Dial Transplant. – 2006. – N.21. –P. 1525-1533.49.Hallan SI, Coresh J, Astor BS, et al.
International comparison of therelationship of chronic kidney disease prevalence and ESRD risk // J AmSoc Nephrol. – 2006. – N.17. – P. 2275-2284.50.Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidneydisease in the general population: follow-up of cross sectional health survey// BMJ. – 2006. – N.333.
– P. 1047.51. Hallan SI, Stevens P. Screening for chronic kidney disease: which strategy?// Nephrology. – 2010. – N.23, Suppl.2. – P. 147-155.52.Haraldson B., Nystrom J., Deen W. Properties of the glomerular barrier andmechanisms of proteinuria // Physiological Reviews. – 2008. – N.88. – P.452-487.53.Haroun N.K., Jaar B.G., Hoffman S.C. et al. Risk factors for chronicKidney disease: a prospective study of 23.534 men and women inWashington Country, Maryland // J. Am. Soc. Nephrol.
– 2003. – N.14. – P.2934-2941.54.Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C,plasma creatinine and the Cockcroft and Gault formula for the estimation of99glomerular filtration rate // Nephrol Dial Transplant. – 2003. –N.18. – P.2024-2031.55.Hogan S., Vupputuri S., Guo X. et al. Association of cigarette smoking withalbuminuria in the United States: the third National Health and NutritionExamination Survey // Ren.Fail. – 2007. – Vol.29, N.2.
– P. 133-142.56.Imai E., Matsuo S., Makino H., Watanabe T. et al.. Chronic Kidney DiseaseJapan Cohort (CKD-JAC) Study: Design and Methods // Hypertens Res. –2008. – Vol.31, N.6. – P. 1101-1107.57. Iseki K., Iseki C, Ikemmiya Y. et al. Risk of development end-stage renaldisease in a cohort mass screening // Kidney Int. - 1996. - Vol. 49. - P.
800805.58. Jaar BC, Khatib R, Plantinga L, Boulware LE, Powe N:Principles ofscreening of chronic kidney disease // Clin J Am Soc Nephrol. – 2008. – N.3. – P. 601–609.59. Jones C.A., McQuillan G.M., Kusek J.W. et al. Serum creatinine levels inthe US population: Third National Health and Nutrition ExaminationSurvey // Am. J. Kidney Dis. - 1998. - Vol. 32. - P. 992-999.60.Kalaitzidis R., Li S., Wang C. et al.
Hypertension in early-stage kidneydisease: an update from the Kidney Early Evaluation Program (KEEP) //Am. J. Kidney Dis. – 2009. – N.53, Suppl.4. – P. 22-31.61.Karter A, Ferrara A, Liu J, Moffet H, Ackerson L, Selby J: Ethnicdisparities in diabetic complications in an insured population // JAMA. –2002. – N.287. – P. 2519–2527.62.Kasiske B.L., Keane W.F.
Laboratory assessment of renal disease:clearance, urinalysis, and renal biopsy // The kidney / Ed. B.M. Brenner. 5th ed.-Brenner&Rector, W.B. Saunders, 1998. - P. 21477-22269.63.KDIGO 2012: Clinical Practice Guideline for the Evaluation andManagement of Chronic Kidney Disease.10064. Klausen KP Scharling H, Jensen G, Jensen JS. New definition ofmicroalbuminuria in hypertensive subjects: association with incidentcoronary heart disease and death // Hypertension. – 2005.
– Vol.46, N.1. –P. 33-37.65.Krol E., Rutkowski B., Czarniak P. et al. Early Detection of ChronicKidney Disease: Results of the PolNef Study // Am J Nephrol. – 2009. –N.29. – P.264-273.66. Kronborg J, Solbu M, Njolstad I et al. Predictors of change in estimatedGFR: a population-based 7-year follow-up from the Tromso study //Nephrology Dialysis Transplantation. – 2008. – N.
23. – P. 2818-2826.67. Kurella M., Chertow G.M., Fried L.F. et al. Chronic kidney disease andcognitive impairment in the elderly: the health, aging, and bodycomposition study // Journal of the American Society of Nephrology. –2005. – Vol.16, N.7. – P.
2127–2133.68.Larsson A, Malm J, Crubb A, Hansson L.O. Calculation of glomerularfiltration rate expressed in ml/min from plasma cystatin C values in mg/L //Scand J Clin Lab Invest. – 2004. – Vol. 64, N. 1. – P. 25-30.69. Larsson A., Malm J., Grubb A., Hansson L.O. Calculation of glomerularfiltration rate expressed in mL/min from plasma cystatin C values in mg/L //Scand J Clin Lab Invest. – 2004. – N.64.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
